Millipore Sigma Vibrant Logo

MAB1345 Anti-Collagen Type VII Antibody, CT, clone LH7.2

View This Product on Sigma-Aldrich
MAB1345
200 µL  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HICCMAscitesMonoclonal Antibody
      Description
      Catalogue NumberMAB1345
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-Collagen Type VII Antibody, CT, clone LH7.2
      References
      Product Information
      FormatAscites
      PresentationAscites. Liquid with 0.1% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-Collagen Type VII Antibody, C-terminus, clone LH7.2 is an antibody against Collagen Type VII for use in IC.
      Key Applications
      • Immunocytochemistry
      Application NotesImmunohistochemistry.

      Optimal working dilutions must be determined by end user.
      Biological Information
      ImmunogenCollagen type VII.
      EpitopeC-terminus
      CloneLH7.2
      HostMouse
      SpecificityCarboxy terminal peptide of type VII collagen.
      IsotypeIgG
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryThis gene encodes the alpha chain of type VII collagen. The type VII collagen fibril, composed of three identical alpha collagen chains, is restricted to the basement zone beneath stratified squamous epithelia. It functions as an anchoring fibril between the external epithelia and the underlying stroma. Mutations in this gene are associated with all forms of dystrophic epidermolysis bullosa. In the absence of mutations, however, an acquired form of this disease can result from an autoimmune response made to type VII collagen.
      Gene Symbol
      • COL7A1
      • EBR1
      • EBD1
      • EBDCT
      UniProt Number
      UniProt SummaryFUNCTION: SwissProt: Q02388 # Stratified squamous epithelial basement membrane protein that forms anchoring fibrils which may contribute to epithelial basement membrane organization and adherence by interacting with extracellular matrix (ECM) proteins such as type IV collagen.
      SIZE: 2944 amino acids; 295220 Da
      SUBUNIT: Homotrimer.
      SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix, basement membrane.
      PTM: Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains.
      DISEASE: SwissProt: Q02388 # Epidermolysis bullosa acquisita (EBA) is an autoimmune acquired blistering skin disease resulting from autoantibodies to type VII collagen. & Defects in COL7A1 are the cause of dystrophic epidermolysis bullosa (DEB) [MIM:131750, 226600]. DEB is a group of blistering skin diseases with either autosomal dominant or autosomal recessive inheritance. Ultrastructurally, DEB is characterized by tissue separation which occurs below the dermal- epidermal basement membrane at the level of the anchoring fibrils. Various clinical types with different severity are recognized. DEB Pasini type is a severe, dominantly inherited form. Among the recessively inherited forms, the Hallopeau-Siemens type epidermolysis bullosa is the most severe form. It manifests with mutilating scarring, joint contractures, corneal erosions, esophagus structures, and propensity to formation of cutaneous squamous cell carcinomas leading to premature demise of the affected individuals. Two milder recessive forms are dystrophic epidermolysis bullosa mitis type and the localized type. The mitis type shows lifelong blistering tendency, with limited scarring and less frequent extracutaneous manifestations. In the localized type, blistering and scarring are predominantly localized to the extremities. & Defects in COL7A1 are the cause of transient bullous dermolysis of the newborn (TBDN) [MIM:131705]. TBDN is a neonatal skin blistering disorder with features similar to those observed in dystrophic epidermolysis bullosa. TBDN is characterized by sub- epidermal blisters, reduced or abnormal anchoring fibrils at the dermo-epidermal junction, and electron-dense inclusions in keratinocytes. TBDN heals spontaneously or strongly improves within the first months and years of life. & Defects in COL7A1 are the cause of pretibial type dystrophic epidermolysis bullosa (P-DEB) [MIM:131850]. Inheritance is autosomal dominant. & Defects in COL7A1 are the cause of Bart type dystrophic epidermolysis bullosa (B-DEB) [MIM:132000]; also known as epidermolysis bullosa with congenital localized absence of skin and deformity of nails. Inheritance is autosomal dominant. & Defects in COL7A1 are the cause of epidermolysis bullosa pruriginosa (EBP) [MIM:604129]. EBP is a distinct clinical subtype of DEB. It is characterized by skin fragility, blistering, scar formation, intense pruritus and excoriated prurigo nodules. Onset is in early childhood, but in some cases is delayed until the second or third decade of life. Inheritance can be autosomal dominant or recessive. & Defects in COL7A1 are the cause of isolated toenail dystrophy without skin fragility [MIM:607523]. & Defects in COL7A1 are the cause of epidermolysis bullosa dystrophica with subcorneal cleavage (EBDSC) [MIM:607600]; also known as epidermolysis bullosa simplex superficialis (EBSS). EBDSC is a new variant of epidermolysis bullosa simplex (EBS), characterized by the development of skin cleavage just beneath the level of stratum corneum. It appears to be transmitted as an autosomal dominant trait and differs from other autosomal dominant forms of EBS by the common findings of milia and atrophic scarring, as well as involvement of oral and/or ocular surfaces. It is further differentiated by the presence of blisters and the absence of spontaneous continual exfoliation or peeling.
      SIMILARITY: SwissProt: Q02388 ## Contains 1 BPTI/Kunitz inhibitor domain. & Contains 9 fibronectin type-III domains. & Contains 2 VWFA domains.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsMaintain at -20°C in convenient aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size200 µL
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      MAB1345 04053252319099

      Documentation

      Anti-Collagen Type VII Antibody, CT, clone LH7.2 SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-Collagen Type VII Antibody, CT, clone LH7.2 Certificates of Analysis

      TitleLot Number
      MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) MONOCLONAL ANTIBODY - 2436422 2436422
      MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) - 2828585 2828585
      MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) - 3172116 3172116
      MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) - 3496528 3496528
      MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) - 3792153 3792153
      MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) - 3984048 3984048
      MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) - 4097763 4097763
      MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) -2705078 2705078
      MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) -2736616 2736616
      MOUSE ANTI-COLLAGEN TYPE VII (HUMAN) MONOCLONAL ANTIBODY 2914964

      References

      Reference overviewPub Med ID
      Novel sutureless keratoplasty with a chemically defined bioadhesive.
      Maho Takaoka, Takahiro Nakamura, Hajime Sugai, Adam J Bentley, Naoki Nakajima, Norihiko Yokoi, Nigel J Fullwood, Suong-Hyu Hyon, Shigeru Kinoshita, Maho Takaoka, Takahiro Nakamura, Hajime Sugai, Adam J Bentley, Naoki Nakajima, Norihiko Yokoi, Nigel J Fullwood, Suong-Hyu Hyon, Shigeru Kinoshita, Maho Takaoka, Takahiro Nakamura, Hajime Sugai, Adam J Bentley, Naoki Nakajima, Norihiko Yokoi, Nigel J Fullwood, Suong-Hyu Hyon, Shigeru Kinoshita
      Investigative ophthalmology visual science  50  2679-85  2009

      Show Abstract
      19136714 19136714
      Novel sutureless transplantation of bioadhesive-coated, freeze-dried amniotic membrane for ocular surface reconstruction.
      Sekiyama, E; Nakamura, T; Kurihara, E; Cooper, LJ; Fullwood, NJ; Takaoka, M; Hamuro, J; Kinoshita, S
      Investigative ophthalmology & visual science  48  1528-34  2007

      Show Abstract
      17389481 17389481
      The quantification of hCLCA2 and colocalisation with integrin beta4 in stratified human epithelia.
      Connon, Che J, et al.
      Acta Histochem., 106: 421-5 (2005)  2005

      Show Abstract
      15707651 15707651
      Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane in vitro, and reduces wound contraction after grafting of cultured skin substitutes.
      Boyce, ST; Supp, AP; Swope, VB; Warden, GD
      The Journal of investigative dermatology  118  565-72  2002

      Show Abstract
      11918700 11918700
      Immunohistochemical characterization of intact stromal layers in long-term cultures of human bone marrow.
      Wilkins, B S and Jones, D B
      Br. J. Haematol., 90: 757-66 (1995)  1995

      Show Abstract
      7669654 7669654

      Related Products & Applications

      Related Products

      Catalogue Number Description  
      MAB2500 Anti-Collagen Type VII Antibody, clone 32,-VII Show Pricing & Availability

      Product Families

      Categories

      Life Science Research > Antibodies and Assays > Primary Antibodies